首页 > 市场调查报告书 > 医疗设备

体外诊断

市场调查报告书

商品编码

1797343

全球IVD原料市场

IVD Raw Materials

出版日期: 2025年08月25日 | 出版商:

Global Industry Analysts, Inc. | 英文 381 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2030年全球IVD原料市场规模将达358亿美元

全球体外诊断 (IVD) 原料市场规模预计在 2024 年达到 277 亿美元，预计在分析期内 (2024-2030 年) 将以 4.3% 的复合年增长率增长，到 2030 年将达到 358 亿美元。作为本报告分析的细分市场之一，体外诊断抗体和抗原市场预计将以 3.8% 的复合年增长率成长，到分析期末将达到 130 亿美元。体外诊断酶市场预计在分析期内以 5.0% 的复合年增长率成长。

美国市场规模估计为 76 亿美元，中国市场预计复合年增长率为 7.8%

美国体外诊断 (IVD) 原料市场规模预计在 2024 年达到 76 亿美元。作为世界第二大经济体，中国市场规模预计到 2030 年将达到 73 亿美元，在 2024-2030 年的分析期内，复合年增长率为 7.8%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为 1.8% 和 3.4%。在欧洲，德国的复合年增长率预计为 2.5%。

全球体外诊断材料市场－主要趋势与驱动因素摘要

原料在体外诊断试剂的可靠性中扮演什么角色？

IVD原料是指用于製造体外诊断检测试剂套件的必需生物、化学和合成成分。这些成分包括抗体、抗原、酵素、核苷酸、试剂、缓衝液、稳定剂和品管。这些原料的品质、一致性和性能直接影响用于检测、监测和筛检疾病的诊断检测方法的敏感度、特异性和可重复性。

分子诊断、就地检验和感染疾病监测的兴起，推动了对可靠体外诊断 (IVD) 原料的需求激增。製造商面临着采购高纯度、批次一致的原材料的压力，以确保合规性和检测可靠性。生技公司和研发部门也依赖体外诊断 (IVD) 级原料来开发肿瘤学、心臟病学和感染疾病的新型检测方案。

哪些创新正在改变材料采购和品质保证？

体外诊断 (IVD) 原料供应商正在投资先进的纯化製程、表达系统和重组生产技术，以满足严格的品质标准。单株抗体生产、合成胜肽合成和酵素工程技术正在不断改进，以提供高产量、可重复的批次。重组抗原和核酸探针越来越多地被用于取代高精度检测套组中可变的生物材料。

材料供应商还提供经过验证的原材料，这些原材料经过稳定性测试、性能文件和可追溯的批次记录，从而简化了体外诊断器械 (IVD) 製造商的监管提交流程。随着测试开发商寻求可靠、扩充性且易于审核的供应商，符合 GMP 标准的生产、ISO 认证和全球分销能力正成为先决条件。一些公司正在开发垂直整合的生产线，以确保在公共卫生危机或需求激增期间不间断供应。

需求集中在哪里？主要买家是谁？

诊断试剂套件製造商、分子检测开发人员和参考实验室的需求最强。开发基于PCR的诊断试剂、ELISA套件、横向流动化验和定序平台的公司依赖针对其特定检测目标量身定制的各种原料。研究机构和生技公司也购买IVD级原料用于检测开发和临床验证。

北美和欧洲仍然是关键市场，因为这些地区诊断公司高度集中且监管严格。亚太地区正经历快速成长，这得益于本地製造的蓬勃发展、疾病监测的不断扩大以及出口能力的提升。随着全球诊断能力的提升，公共卫生实验室、学术机构和合约诊断製造商正在扩大原料的使用。

推动IVD原料市场成长的因素有哪些？

IVD原材料市场的成长受到多种因素的推动，包括全球对诊断检测的需求不断增长、检测方式日益复杂以及对原材料品质的监管审查日益严格。重组生产、合成化学和表达系统的进步，使得高性能组件的可靠且可扩展的供应成为可能。

分子诊断、传染病检查和个人化医疗等领域的终端应用不断扩展，对高度特异性和稳定性原料的需求持续成长。新型病原体的出现、对分散式检查的重视以及实验室基础设施投资的增加，进一步推动了原材料的使用。随着诊断成为预防医学和精准医疗的核心，成熟和新兴医疗保健市场对高品质体外诊断 (IVD) 原料的需求持续成长。

部分

产品（体外诊断试剂抗体抗原、体外诊断试剂酶、体外诊断试剂蛋白质、体外诊断试剂生物缓衝液等产品）、技术（临床化学技术、免疫化学技术、分子诊断技术等技术）及终端用户（製药及生技公司、诊断实验室等终端用户）。

受访公司范例

Aalto Bio Reagents Ltd.
AMSBIO（AMS Biotechnology）
BBI Solutions
Bio-Rad Laboratories, Inc.
Bio-Check（UK）Ltd
Bioporto Diagnostics
Diarect AG
EastCoast Bio
Fitzgerald Industries Intl.
Fujirebio
HyTest Ltd
Jena Bioscience GmbH
Medix Biochemica
Meridian Bioscience, Inc.
MyBiosource, Inc.
QuidelOrtho Corporation
RayBiotech, Inc.
Rockland Immunochemicals, Inc.
Scripps Laboratories, Inc.
Sekisui Diagnostics

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 没有遵循典型的 LLM 或特定于行业的 SLM查询，而是建立了一个从世界各地的专家收集的内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

The global market for IVD Raw Materials estimated at US$27.7 Billion in the year 2024, is expected to reach US$35.8 Billion by 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. IVD Antibody & Antigens, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$13.0 Billion by the end of the analysis period. Growth in the IVD Enzymes segment is estimated at 5.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$7.6 Billion While China is Forecast to Grow at 7.8% CAGR

The IVD Raw Materials market in the U.S. is estimated at US$7.6 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$7.3 Billion by the year 2030 trailing a CAGR of 7.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.8% and 3.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.

Global IVD Raw Materials Market - Key Trends & Drivers Summarized

What Role Do Raw Materials Play in the Reliability of In Vitro Diagnostics?

IVD raw materials refer to the essential biological, chemical, and synthetic components used in the manufacture of in vitro diagnostic tests and kits. These include antibodies, antigens, enzymes, nucleotides, reagents, buffers, stabilizers, and control materials. The quality, consistency, and performance of these raw inputs directly impact the sensitivity, specificity, and reproducibility of diagnostic assays used for disease detection, monitoring, and screening.

Demand for reliable IVD raw materials has surged with the rise in molecular diagnostics, point-of-care testing, and infectious disease surveillance. Manufacturers are under pressure to source high-purity, lot-consistent raw materials to ensure regulatory compliance and assay reliability. Biotech firms and research labs also depend on IVD-grade materials for developing new test formats in oncology, cardiology, and infectious diseases.

What Innovations Are Transforming Material Sourcing and Quality Assurance?

Suppliers of IVD raw materials are investing in advanced purification processes, expression systems, and recombinant production technologies to meet stringent quality standards. Monoclonal antibody production, synthetic peptide synthesis, and enzyme engineering are being refined to deliver high-yield, reproducible batches. Recombinant antigens and nucleic acid probes are being used to replace variable biological materials in high-precision test kits.

Material suppliers are also offering pre-validated raw inputs with stability testing, performance documentation, and traceable lot records to streamline regulatory filings by IVD manufacturers. GMP-compliant manufacturing, ISO certifications, and global distribution capabilities are becoming prerequisites as test developers seek reliable, scalable, and audit-ready suppliers. Some companies are developing vertically integrated production lines to ensure uninterrupted supply during public health crises or demand surges.

Where Is Demand Concentrated, and Who Are the Leading Buyers?

Demand is strongest among diagnostic kit manufacturers, molecular test developers, and reference laboratories. Companies developing PCR-based diagnostics, ELISA kits, lateral flow assays, and sequencing platforms rely on a wide range of raw materials tailored to specific detection targets. Research organizations and biotech firms also purchase IVD-grade materials for assay development and clinical validation.

North America and Europe remain key markets due to the concentration of diagnostics firms and regulatory stringency. Asia Pacific is growing rapidly, driven by local manufacturing initiatives, expanding disease surveillance, and increasing export capacity. Public health laboratories, academic institutions, and contract diagnostic manufacturers are expanding their raw material usage as global diagnostic capacity grows.

What Is Driving Growth in the IVD Raw Materials Market?

Growth in the IVD raw materials market is driven by several factors including rising global demand for diagnostic testing, increasing complexity of assay formats, and heightened regulatory scrutiny of material quality. Advances in recombinant production, synthetic chemistry, and expression systems are enabling reliable, scalable supply of high-performance components.

End-use expansion in molecular diagnostics, infectious disease testing, and personalized medicine is creating recurring demand for highly specific and stable raw materials. Emergence of new pathogens, focus on decentralized testing, and growing investment in lab infrastructure are further boosting usage. As diagnostics become central to preventive and precision medicine, the need for high-quality IVD raw materials continues to grow in both established and emerging healthcare markets.

SCOPE OF STUDY:

The report analyzes the IVD Raw Materials market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers, Other Products); Technology (Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology, Other Technologies); End-Use (Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 39 Featured) -

Aalto Bio Reagents Ltd.
AMSBIO (AMS Biotechnology)
BBI Solutions
Bio-Rad Laboratories, Inc.
Bio-Check (UK) Ltd
Bioporto Diagnostics
Diarect AG
EastCoast Bio
Fitzgerald Industries Intl.
Fujirebio
HyTest Ltd
Jena Bioscience GmbH
Medix Biochemica
Meridian Bioscience, Inc.
MyBiosource, Inc.
QuidelOrtho Corporation
RayBiotech, Inc.
Rockland Immunochemicals, Inc.
Scripps Laboratories, Inc.
Sekisui Diagnostics

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Tariff Impact on Global Supply Chain Patterns
- IVD Raw Materials - Global Key Competitors Percentage Market Share in 2025 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Rising Demand for In Vitro Diagnostics Across Infectious Disease, Cancer, and Genetic Testing Drives Consumption of Raw Materials
- Expansion of Point-of-Care and Home Diagnostics Strengthens Need for High-Quality Antibodies, Antigens, and Buffers
- OEM Focus on Recombinant Protein Engineering and Monoclonal Antibody Production Enhances Specificity and Stability
- Growth in Molecular Diagnostics and PCR-Based Assays Throws Spotlight on High-Fidelity Enzymes and Primers
- Increasing Emphasis on Supply Chain Resilience and Material Traceability Supports Strategic Sourcing of IVD Inputs
- OEM Investment in GMP-Compliant Raw Material Manufacturing Improves Quality Assurance for Diagnostic Kit Producers
- Rising Adoption of Multiplex Assays and Rapid Diagnostic Tests Fuels Need for Custom Coating and Blocking Reagents
- OEM Development of Bulk Supply Agreements With Test Kit Manufacturers Enhances Scalability and Delivery Reliability
- Growth in Companion Diagnostics and Personalized Medicine Expands Use of Specialized Biomarker Reagents
- OEM Innovation in Lyophilized and Room-Temperature Stable Raw Materials Supports Distribution in Low-Resource Settings
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World IVD Raw Materials Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
- TABLE 2: World Recent Past, Current & Future Analysis for IVD Raw Materials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 3: World Historic Review for IVD Raw Materials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 4: World 16-Year Perspective for IVD Raw Materials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
- TABLE 5: World Recent Past, Current & Future Analysis for IVD Antibody & Antigens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 6: World Historic Review for IVD Antibody & Antigens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 7: World 16-Year Perspective for IVD Antibody & Antigens by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 8: World Recent Past, Current & Future Analysis for IVD Enzymes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 9: World Historic Review for IVD Enzymes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 10: World 16-Year Perspective for IVD Enzymes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 11: World Recent Past, Current & Future Analysis for IVD Proteins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 12: World Historic Review for IVD Proteins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 13: World 16-Year Perspective for IVD Proteins by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 14: World Recent Past, Current & Future Analysis for IVD Biological Buffers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 15: World Historic Review for IVD Biological Buffers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 16: World 16-Year Perspective for IVD Biological Buffers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 17: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 18: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 19: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 20: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 21: World Historic Review for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 22: World 16-Year Perspective for Pharma & Biotech Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 23: World Recent Past, Current & Future Analysis for Diagnostic Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 24: World Historic Review for Diagnostic Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 25: World 16-Year Perspective for Diagnostic Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 28: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 29: World Recent Past, Current & Future Analysis for Clinical Chemistry Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 30: World Historic Review for Clinical Chemistry Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 31: World 16-Year Perspective for Clinical Chemistry Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 32: World Recent Past, Current & Future Analysis for Immunochemistry Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 33: World Historic Review for Immunochemistry Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 34: World 16-Year Perspective for Immunochemistry Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 35: World Recent Past, Current & Future Analysis for Molecular Diagnostics Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 36: World Historic Review for Molecular Diagnostics Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 37: World 16-Year Perspective for Molecular Diagnostics Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 38: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 39: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 40: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

UNITED STATES
- IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
- TABLE 41: USA Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 42: USA Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 43: USA 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
- TABLE 44: USA Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 45: USA Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 46: USA 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 47: USA Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 48: USA Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 49: USA 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
CANADA
- TABLE 50: Canada Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 51: Canada Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 52: Canada 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
- TABLE 53: Canada Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 54: Canada Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 55: Canada 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 56: Canada Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 57: Canada Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 58: Canada 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
JAPAN
- IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
- TABLE 59: Japan Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 60: Japan Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 61: Japan 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
- TABLE 62: Japan Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 63: Japan Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 64: Japan 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 65: Japan Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 66: Japan Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 67: Japan 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
CHINA
- IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
- TABLE 68: China Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 69: China Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 70: China 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
- TABLE 71: China Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 72: China Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 73: China 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 74: China Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 75: China Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 76: China 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
EUROPE
- IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
- TABLE 77: Europe Recent Past, Current & Future Analysis for IVD Raw Materials by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 78: Europe Historic Review for IVD Raw Materials by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 79: Europe 16-Year Perspective for IVD Raw Materials by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
- TABLE 80: Europe Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 81: Europe Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 82: Europe 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
- TABLE 83: Europe Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 84: Europe Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 85: Europe 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 86: Europe Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 87: Europe Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 88: Europe 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
FRANCE
- IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
- TABLE 89: France Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 90: France Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 91: France 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
- TABLE 92: France Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 93: France Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 94: France 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 95: France Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 96: France Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 97: France 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
GERMANY
- IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
- TABLE 98: Germany Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 99: Germany Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 100: Germany 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
- TABLE 101: Germany Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 102: Germany Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 103: Germany 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 104: Germany Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 105: Germany Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 106: Germany 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
ITALY
- TABLE 107: Italy Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 108: Italy Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 109: Italy 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
- TABLE 110: Italy Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 111: Italy Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 112: Italy 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 113: Italy Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 114: Italy Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 115: Italy 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
UNITED KINGDOM
- IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
- TABLE 116: UK Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 117: UK Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 118: UK 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
- TABLE 119: UK Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 120: UK Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 121: UK 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 122: UK Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 123: UK Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 124: UK 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
SPAIN
- TABLE 125: Spain Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 126: Spain Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 127: Spain 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
- TABLE 128: Spain Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 129: Spain Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 130: Spain 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 131: Spain Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 132: Spain Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 133: Spain 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
RUSSIA
- TABLE 134: Russia Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 135: Russia Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 136: Russia 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
- TABLE 137: Russia Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 138: Russia Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 139: Russia 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 140: Russia Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 141: Russia Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 142: Russia 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
REST OF EUROPE
- TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 144: Rest of Europe Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 145: Rest of Europe 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
- TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 147: Rest of Europe Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 148: Rest of Europe 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 150: Rest of Europe Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 151: Rest of Europe 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
ASIA-PACIFIC
- IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
- TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for IVD Raw Materials by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 153: Asia-Pacific Historic Review for IVD Raw Materials by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 154: Asia-Pacific 16-Year Perspective for IVD Raw Materials by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
- TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 156: Asia-Pacific Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 157: Asia-Pacific 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
- TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 159: Asia-Pacific Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 160: Asia-Pacific 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 162: Asia-Pacific Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 163: Asia-Pacific 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
AUSTRALIA
- IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
- TABLE 164: Australia Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 165: Australia Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 166: Australia 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
- TABLE 167: Australia Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 168: Australia Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 169: Australia 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 170: Australia Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 171: Australia Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 172: Australia 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
INDIA
- IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
- TABLE 173: India Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 174: India Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 175: India 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
- TABLE 176: India Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 177: India Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 178: India 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 179: India Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 180: India Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 181: India 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
SOUTH KOREA
- TABLE 182: South Korea Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 183: South Korea Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 184: South Korea 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
- TABLE 185: South Korea Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 186: South Korea Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 187: South Korea 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 188: South Korea Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 189: South Korea Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 190: South Korea 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
REST OF ASIA-PACIFIC
- TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 192: Rest of Asia-Pacific Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 193: Rest of Asia-Pacific 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
- TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 195: Rest of Asia-Pacific Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 196: Rest of Asia-Pacific 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 198: Rest of Asia-Pacific Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 199: Rest of Asia-Pacific 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
LATIN AMERICA
- IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
- TABLE 200: Latin America Recent Past, Current & Future Analysis for IVD Raw Materials by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 201: Latin America Historic Review for IVD Raw Materials by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 202: Latin America 16-Year Perspective for IVD Raw Materials by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
- TABLE 203: Latin America Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 204: Latin America Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 205: Latin America 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
- TABLE 206: Latin America Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 207: Latin America Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 208: Latin America 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 209: Latin America Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 210: Latin America Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 211: Latin America 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
ARGENTINA
- TABLE 212: Argentina Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 213: Argentina Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 214: Argentina 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
- TABLE 215: Argentina Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 216: Argentina Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 217: Argentina 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 218: Argentina Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 219: Argentina Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 220: Argentina 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
BRAZIL
- TABLE 221: Brazil Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 222: Brazil Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 223: Brazil 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
- TABLE 224: Brazil Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 225: Brazil Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 226: Brazil 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 227: Brazil Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 228: Brazil Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 229: Brazil 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
MEXICO
- TABLE 230: Mexico Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 231: Mexico Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 232: Mexico 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
- TABLE 233: Mexico Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 234: Mexico Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 235: Mexico 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 236: Mexico Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 237: Mexico Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 238: Mexico 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
REST OF LATIN AMERICA
- TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 240: Rest of Latin America Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 241: Rest of Latin America 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
- TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 243: Rest of Latin America Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 244: Rest of Latin America 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 246: Rest of Latin America Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 247: Rest of Latin America 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
MIDDLE EAST
- IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
- TABLE 248: Middle East Recent Past, Current & Future Analysis for IVD Raw Materials by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 249: Middle East Historic Review for IVD Raw Materials by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 250: Middle East 16-Year Perspective for IVD Raw Materials by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
- TABLE 251: Middle East Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 252: Middle East Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 253: Middle East 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
- TABLE 254: Middle East Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 255: Middle East Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 256: Middle East 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 257: Middle East Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 258: Middle East Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 259: Middle East 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
IRAN
- TABLE 260: Iran Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 261: Iran Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 262: Iran 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
- TABLE 263: Iran Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 264: Iran Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 265: Iran 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 266: Iran Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 267: Iran Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 268: Iran 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
ISRAEL
- TABLE 269: Israel Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 270: Israel Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 271: Israel 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
- TABLE 272: Israel Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 273: Israel Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 274: Israel 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 275: Israel Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 276: Israel Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 277: Israel 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
SAUDI ARABIA
- TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 279: Saudi Arabia Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 280: Saudi Arabia 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
- TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 282: Saudi Arabia Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 283: Saudi Arabia 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 285: Saudi Arabia Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 286: Saudi Arabia 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
UNITED ARAB EMIRATES
- TABLE 287: UAE Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 288: UAE Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 289: UAE 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
- TABLE 290: UAE Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 291: UAE Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 292: UAE 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 293: UAE Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 294: UAE Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 295: UAE 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
REST OF MIDDLE EAST
- TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 297: Rest of Middle East Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 298: Rest of Middle East 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
- TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 300: Rest of Middle East Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 301: Rest of Middle East 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 303: Rest of Middle East Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 304: Rest of Middle East 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
AFRICA
- IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
- TABLE 305: Africa Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 306: Africa Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 307: Africa 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
- TABLE 308: Africa Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 309: Africa Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 310: Africa 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 311: Africa Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 312: Africa Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 313: Africa 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030